94429-8
HLA-DP and DQ and DR (class II) IgG low risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
Active
Term Description
Laboratories that perform HLA antibody testing often report the specific antibodies found in categories based on the "amount" of each antibody found (called mean fluorescent intensity, MFI, for the common Luminex bead method). Theoretically, the antibodies present in higher concentrations, which are more likely to react with donor antigens, will have higher MFI values. Since risk stratification based on MFI range is not standardized and the exact cutoffs vary from lab to lab, this term is intended to report those HLA antibodies found in the lower risk stratification of MFI values, but still detectable and possibly having a risk of rejection (For one lab this range was 500 < MFI < 1999).
LOINC Names Get Info
- Fully-Specified Name
- HLA-DP & DQ & DR (class II) Ab.IgG low risk:
Prid: Pt: Ser/Plas: Nom: Flow cytometry - Long Common Name
- HLA-DP and DQ and DR (class II) IgG low risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
- Short Name
- HLA class II Ab.IgG low risk SerPl FC
- Display Name
- HLA-DP & DQ & DR (class II) Ab.IgG low risk FC Nom
- Consumer Name Alpha Get Info
- HLA-DP & DQ & DR (class II) Ab.IgG low risk, Blood
Part Model Get Info
- Component
- HLA-DP & DQ & DR (class II) Ab.IgG low risk
LP417716-0
- Analyte
- HLA-DP & DQ & DR (class II) Ab.IgG low risk
LP417716-0
- Component Numerator
- HLA-DP & DQ & DR (class II) Ab.IgG low risk
LP417716-0
- Component Numerator Core
- HLA-DP & DQ & DR (class II) Ab.IgG low risk
LP417716-0
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Prid
LP6850-4
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser/Plas
LP7576-4
- System Core
- Ser/Plas
LP7576-4
- Super System
- NULL
- Scale
- Nom
LP7750-5
- Method
- Flow cytometry
LP6274-7
Example Answer List: LL3602-1
Source: NCBI PubMed| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Anti-DP1 | LA23895-8 | ||
| Anti-DP2 | LA23894-1 | ||
| Anti-DP3 | LA23897-4 | ||
| Anti-DP4 | LA23896-6 | ||
| Anti-DP5 | LA23898-2 | ||
| Anti-DP6 | LA23899-0 | ||
| Anti-DQ1 | LA23909-7 | ||
| Anti-DQ2 | LA23906-3 | ||
| Anti-DQ3 | LA23907-1 | ||
| Anti-DQ4 | LA23908-9 | ||
| Anti-DQ5(1) | LA23903-0 | ||
| Anti-DQ6(1) | LA23902-2 | ||
| Anti-DQ7(3) | LA23904-8 | ||
| Anti-DQ8(3) | LA23905-5 | ||
| Anti-DR1 | LA23910-5 | ||
| Anti-DR3 | LA23914-7 | ||
| Anti-DR4 | LA23915-4 | ||
| Anti-DR6 | LA23922-0 | ||
| Anti-DR7 | LA23916-2 | ||
| Anti-DR8 | LA23917-0 | ||
| Anti-DR10 | LA23918-8 | ||
| Anti-DR11(5) | LA23919-6 | ||
| Anti-DR12(5) | LA23920-4 | ||
| Anti-DR13(6) | LA23921-2 | ||
| Anti-DR14(6) | LA23923-8 | ||
| Anti-DR15(2) | LA23924-6 | ||
| Anti-DR16(2) | LA23925-3 | ||
| Anti-DR17(3) | LA23912-1 | ||
| Anti-DR18(3) | LA23913-9 | ||
| Anti-DR51 | LA23927-9 | ||
| Anti-DR52 | LA23926-1 | ||
| Anti-DR53 | LA23928-7 | ||
| Anti-DR103 | LA23911-3 |
Basic Attributes
- Class
- HLA
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.68 (ADD)
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 94428-0 | HLA class I and II IgG panel - Serum or Plasma by Flow cytometry (FC) |
| 94440-5 | HLA-DP and DQ and DR (class II) IgG panel - Serum or Plasma by Flow cytometry (FC) |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | HLA-DP a DQ a DR (třída II) IgG nízké riziko: |
| el-GR | Greek (Greece) | Ανθρώπινα λευκοκυτταρικά αντιγόνα-DP & DQ & DR (Κατηγορία IΙ) Αντισώματα IgG χαμηλού κινδύνου: Synonyms: dP Nom Prid Pt Ανθρώπινα λευκοκυτταρικά αντιγόνα Ανθρώπινα λευκοκυτταρικά αντιγόνα-DP Ανθρώπινα λευκοκυτταρικά αντιγόνα-DP & |
| es-ES | Spanish (Spain) | HLA-DP, DQ, DR (class II) bajo riesgo por Ac IgG: |
| es-MX | Spanish (Mexico) | HLA-DP & DQ & DR (clase II) Ab.IgG bajo riesgo: |
| fr-FR | French (France) | HLA-DP et DQ et DR (classe II) anticorps IgG MFI faible: |
| it-IT | Italian (Italy) | HLA-DP & DQ & DR (classe II) Ab.IgG, rischio basso: Synonyms: Citometria a flusso (FC) HLA tipizzazione tissutale antigeni-anticorpi HLA-DP e DQ e DR (classe II) Plasma Presenza o Identità Pressione differenziale Punto nel tempo (episodio) Rischio basso di HLA-DP e DQ eDR (classe II) Ab.IgG Siero Siero o Plasma |
| nl-NL | Dutch (Netherlands) | HLA-DP & DQ & DR (klasse II) As.IgG laag risico: |
| pl-PL | Polish (Poland) | HLA-DP & DQ & DR (klasa II) Ab.IgG niskiego ryzyka: Synonyms: HLA-DP i DQ i DR (klasa II) HLA-DP, DQ i DR IgG Przeciwciała IgG do HLA-DP, DQ i DR (klasa II) Przeciwciała IgG do HLA-DP, DQ i DR (klasa II) niskiego ryzyka wynik kategorialny |
| zh-CN | Chinese (China) | HLA-DP 与 DQ 与 DR (II 类) 抗体.IgG 低度风险: Synonyms: HLA II 类; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://